IPSC — Century Therapeutics, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-06-18.
Performance
Technicals
Others in Healthcare
Measured signals that fired on IPSC
| date | signal | measured base rate |
|---|---|---|
| 2026-08-03 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-07-28 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-06-26 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
| 2026-05-15 | Institutional holders jumped in a quarter ownership | -0.52% over 21 days · t = -0.38 · n = 1,553 not distinguishable from its control group |
| 2026-02-26 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-14 | Pfeiffenberger Brent President and CEO | Shares withheld for tax | 31.2K | 1.92 | 59.9K |
| 2026-08-03 | Carr Douglas SVP Finance & Operations | Open-market sale | 275 | 1.98 | 544 |
| 2026-06-12 | Russotti Gregory See Remarks | Open-market sale | 2.6K | 2.23 | 5.8K |
| 2026-06-12 | Carr Douglas SVP Finance & Operations | Open-market sale | 1.7K | 2.23 | 3.7K |
| 2026-06-11 | Pfeiffenberger Brent President and CEO | Shares withheld for tax | 13.8K | 2.24 | 31.0K |
| 2026-06-11 | Cowan Chad Chief Scientific Officer | Shares withheld for tax | 358 | 2.24 | 802 |
| 2026-06-08 | Russotti Gregory See Remarks | Open-market sale | 524 | 2.11 | 1.1K |
| 2026-06-08 | Carr Douglas SVP Finance & Operations | Open-market sale | 249 | 2.11 | 526 |
| 2026-06-05 | Pfeiffenberger Brent President and CEO | Shares withheld for tax | 463 | 2.13 | 986 |
| 2026-05-15 | Pfeiffenberger Brent President and CEO | Shares withheld for tax | 31.2K | 2.34 | 72.9K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 40.1M | 17.8M |
| TCG Crossover Management, LLC | 39.0M | 17.8M |
| Versant Venture Management, LLC | 27.5M | 12.2M |
| Deep Track Capital, LP | 21.4M | 9.5M |
| Venrock Adviser, LLC | 19.7M | 8.7M |
| RTW INVESTMENTS, LP | 19.7M | 8.7M |
| Commodore Capital LP | 19.7M | 8.7M |
| Point72 Asset Management, L.P. | 13.5M | 6.0M |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.9M | 5.7M |
| Balyasny Asset Management L.P. | 11.3M | 5.0M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Century Therapeutics, Inc. (IPSC) filed form 8-K · 2026-08-12 · SEC EDGAR
- Century Therapeutics GAAP EPS of -$0.17 misses by $0.05 · 2026-08-12
Ask the AI about IPSC
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →